Skip to Main content Skip to Navigation
Journal articles

Long-lasting severe immune dysfunction in Ebola virus disease survivors

Abstract : Long-term follow up studies from Ebola virus disease (EVD) survivors (EBOV_S) are lacking. Here, we evaluate immune and gene expression profiles in 35 Guinean EBOV_S from the last West African outbreak, a median of 23 months (IQR [18-25]) after discharge from treatment center. Compared with healthy donors, EBOV_S exhibit increases of blood markers of inflammation, intestinal tissue damage, T cell and B cell activation and a depletion of circulating dendritic cells. All survivors have EBOV-specific IgG antibodies and robust and polyfunctional EBOV-specific memory T-cell responses. Deep sequencing of the genes expressed in blood reveals an enrichment in 'inflammation' and 'antiviral' pathways. Integrated analyses identify specific immune markers associated with the persistence of clinical symptoms. This study identifies a set of biological and genetic markers that could be used to define a signature of "chronic Ebola virus disease (CEVD)".
Complete list of metadata

Cited literature [56 references]  Display  Hide  Download
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Tuesday, September 29, 2020 - 10:44:23 AM
Last modification on : Friday, April 1, 2022 - 2:24:56 PM


Publication funded by an institution




Aurélie Wiedemann, Emile Foucat, Hakim Hocini, Cécile Lefebvre, Boris Hejblum, et al.. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.3730. ⟨10.1038/s41467-020-17489-7⟩. ⟨hal-03160838v2⟩



Record views


Files downloads